This test can be used to determine the treatment response and recurrence in patients confirmed to have a BRAF mutation among companion dog patients with malignant tumors.

It is possible to compare whether mutations are quantitatively increased or decreased by using consecutive samples from the same patient.

Gene mutations are tested using the dog’s urine, and thus please provide a blood sample for comparison.